CIB-L43

Customer Review

Based on 1 Customer Validation

CIB-L43 is an orally active TRBP inhibitor (KD = 4.78 nM) and enhances disruption of TRBP-Dicer interactions (IC50 = 2.34 μM). CIB-L43 suppresses oncogenic miR-21 biosynthesis, increasing PTEN and Smad7 expression and inhibiting AKT and TGF-β signaling, thereby reducing HCC cell proliferation and migration.

For research use only. We do not sell to patients.

  • Purity: 99.71%
  • CAS No.: 1082942-70-8
  • Formula: C15H16N2O3S
  • Molecular Weight:304.36
  • Storage:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Purity & Documentation
  • References
  • Help & FAQs
You May Still Need

All TGF-beta/Smad Isoforms

More

All Akt Isoforms

More
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00